Toronto woman with rare cancer fighting to have nearly $80K/month treatment covered by the province
A Toronto woman with cancer is fighting to have her nearly $80,000 per month treatment covered by the province, which has already been rejected twice. In March of last year, Holly Woodridge, a University of Toronto professor, went to her doctor after feeling unwell. She was eventually diagnosed with cholangiocarcinoma, a rare but aggressive cancer […]
A Toronto woman, Holly Woodridge, is a professor at the University of Toronto who has been diagnosed with an aggressive form of liver cancer, cholangiocarcinoma. Despite initial treatment with chemotherapy and immunotherapy, the cancer has not responded enough to warrant a liver transplant. Recently, Woodridge's oncologist introduced her to zenocutuzumab, a targeted therapy specifically designed to combat her particular tumor mutation, avoiding any systemic side effects of chemotherapy.
Since mid-April, Woodridge has been receiving this treatment, which has led to significant tumor reduction. However, this innovative therapy is only available in the United States and costs around $78,000 per month. With her savings depleted and family and friends providing assistance, Woodridge has launched a GoFundMe campaign to cover the hefty expenses.
Her application for funding from Ontario's Cancer Care Ontario program, which reviews funding requests for patients in dire need, has been rejected twice. The reason for denial is that the drug is still part of an ongoing clinical trial in the United States, and it has not received approval from Health Canada, the governing body for drug authorization in Canada.
The Ministry of Health declined to comment on individual cases, stating that Health Canada is responsible for determining the drug's approval within Canada. Partner Therapeutics, the drug's manufacturer, has no plans to file for full approval in Canada at the moment, but they do support named patient access globally.
Written by urgent.news from CityNews's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.